To directly test that hypothesis, we obtained maternal Env-specific IgG MAbs from nontransmitting and transmitting HIV-infected U.S. and Malawian women and tested their neutralization activities against maternal circulating viruses present near the time of infant exposure/infection (nontransmitted variants) and against infant-T/F viruses. Here, ERVW-1 is linked to infection.